Physician profile
David J Cahn
NPI 1275561748
$58,078.10
in general payments reported to CMS, 2019-2025
64 companies · $22K in 2025
The $22K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,957 · 2020: $3,218 · 2021: $4,843 · 2022: $4,627 · 2023: $9,465 · 2024: $12K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $6,400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,160 · Travel and Lodging: $4,984 · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,388.75 |
| Food and Beverage | $6,399.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,160.00 |
| Travel and Lodging | $4,983.58 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15,497.97 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $10,607.99 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $8,902.25 | 2020-2025 | Erleada, Akeega |
| Astrazeneca Pharmaceuticals LP | $4,211.14 | 2021-2025 | Imfinzi, Truqap, Lynparza |
| Urogen Pharma, INC. | $2,895.28 | 2022-2025 | Jelmyto |
| Pfizer INC. | $2,687.66 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,400.00 | 2025 | |
| Telix Pharmaceuticals | $1,891.98 | 2024 | Illuccix |
| Janssen Research & Development, LLC | $1,737.36 | 2020-2024 | Erleada |
| Dendreon Pharmaceuticals LLC | $1,192.21 | 2019-2025 | Provenge |
| Merck Sharp & Dohme LLC | $857.30 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Boston Scientific Corporation | $573.08 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, Lithovue |
| Astellas Pharma US INC | $488.76 | 2019-2024 | Xtandi |
| Abbvie INC. | $357.99 | 2019-2025 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $303.00 | 2019-2024 | Xiaflex, Aveed, Edex |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $260.59 | 2024-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $258.19 | 2021-2022 | |
| Axonics, INC. | $237.51 | 2021-2024 | Bulkamid, Axonics |
| Antares Pharma, INC. | $187.23 | 2019-2022 | |
| Neotract INC. | $182.00 | 2019 | |
| Procept Biorobotics Corporation | $165.10 | 2023 | Aquabeam Robotic System |
| Medtronic, INC. | $162.57 | 2021-2024 | Interstim, Nuro |
| Tolmar Pharmaceuticals, INC. | $156.17 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $150.57 | 2019-2025 | Adstiladrin |
| Rochester Medical Corporation | $136.23 | 2020-2022 | |
| Tolmar, INC. | $125.46 | 2024-2025 | Eligard, Jatenzo |
| Convatec INC. | $118.88 | 2024-2025 | |
| Coloplast Corp | $91.34 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $89.60 | 2022-2025 | |
| Baxter Healthcare | $88.93 | 2024 | Perclot, Floseal |
| Teleflex LLC | $87.33 | 2022-2025 | Barrigel |
| Progenics Pharmaceuticals, INC. | $86.77 | 2022-2025 | Pylarify |
| Blue Earth Diagnostics | $84.95 | 2019-2025 | Posluma |
| Endo USA, INC. | $74.25 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $69.77 | 2019-2023 | Cure Ultra Catheter |
| Sun Pharmaceutical Industries INC. | $63.73 | 2023-2024 | Yonsa |
| Ambu INC. | $56.63 | 2022-2023 | |
| Hollister Incorporated | $47.04 | 2022-2023 | Vapro Plus Pocket |
| Amgen INC. | $38.38 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $36.35 | 2019 | |
| Laborie Medical Technologies Corp. | $36.33 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Caris Mpi, INC. | $35.07 | 2025 | Mi Cancer Seek |
| Olympus America INC. | $34.89 | 2021-2025 | Itind System |
| Cardinal Health 414 LLC | $30.86 | 2025 | |
| Medtronic USA, INC. | $28.94 | 2020 | |
| Dentsply Ih INC. | $28.88 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $25.74 | 2021-2022 | |
| Innovation Technologies INC | $21.15 | 2023 | Irrisept |
| Tempus Ai, INC | $21.14 | 2024 | |
| Steris Corporation | $20.58 | 2024 | |
| Photocure INC | $19.07 | 2022 | |
| Agiliti Surgical, INC. | $18.58 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $17.49 | 2023 | Seglentis |
| Travere Therapeutics, INC. | $15.73 | 2021 | |
| Biotissue Holdings INC. | $14.75 | 2024 | |
| Foundation Medicine, INC. | $13.33 | 2023 | |
| Intuitive Surgical, INC. | $12.43 | 2022 | |
| Acerus Pharmaceuticals Corporation | $11.97 | 2022 | |
| Allergan, INC. | $11.63 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$22,126.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.